Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Effect of vitamin D status on antibody production in Omicron variant‐infected patients.
Source: Effect of vitamin D status on antibody production. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
Source: Article title.
This investigation involving human participants were reviewed and approved by the Ethics Committee of The Third People's Hospital of Shenzhen (approval number: 2022‐100).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
Cohort study · The Clinical Respiratory Journal · 2023
Original publication title
Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
© 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults need to be further explored.
Source: IntroductionAbstract: What methods does the paper describe?
A retrospective, longitudinal, real‐world cohort study was performed. All included cases were divided into vitamin D deficiency (VDD) and non‐VDD (control) groups according to baseline serum 25‐hydroxyvitamin D [25(OH)D] concentration and then into unvaccinated, routinely vaccinated, and booster vaccinated VDD and control subgroups according to vaccination status. Antibody dynamics were observed within six time periods during hospitalization.
Source: MethodsAbstract: Results
A total of 204 adult cases were included, of which 121 (59%) were males; 23 (11%), 31 (15%), and 26 (13%) or 50 (25%), 35 (17%), and 39 (19%) were unvaccinated, routinely vaccinated, and booster vaccinated VDD cases or controls, respectively. The median (interquartile range) for age and baseline 25(OH)D concentration was 42.5 (31 to 53.5) years and 21.5 (18 to 25.4) ng/mL, respectively. The IgM titers within 3 to 7 days and 7 to 14 days increased rapidly to 1.8‐fold (P < 0.001) and 3.6‐fold (P < 0.001) those within the first day; the IgG titers increased to 5.8‐fold (P < 0.001) and 10.9‐fold (P < 0.001).
Booster vaccinated controls had higher first IgG titers compared with unvaccinated controls (3.1‐fold; P = 0.001) or booster vaccinated VDD cases (2.1‐fold; P = 0.02).
Source: ResultsAbstract: Conclusions
Booster vaccination and non‐VDD status may have an interactive boosting effect on IgG production of Omicron variant‐infected adults. Further randomized clinical trials may be needed to determine whether booster vaccination combined with VDD correction improves the humoral immunity to Omicron variants.
Source: ConclusionsAuthors’ abstract
Abstract
Introduction
Effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults need to be further explored.
Methods
A retrospective, longitudinal, real‐world cohort study was performed. All included cases were divided into vitamin D deficiency (VDD) and non‐VDD (control) groups according to baseline serum 25‐hydroxyvitamin D [25(OH)D] concentration and then into unvaccinated, routinely vaccinated, and booster vaccinated VDD and control subgroups according to vaccination status. Antibody dynamics were observed within six time periods during hospitalization.
Results
A total of 204 adult cases were included, of which 121 (59%) were males; 23 (11%), 31 (15%), and 26 (13%) or 50 (25%), 35 (17%), and 39 (19%) were unvaccinated, routinely vaccinated, and booster vaccinated VDD cases or controls, respectively. The median (interquartile range) for age and baseline 25(OH)D concentration was 42.5 (31 to 53.5) years and 21.5 (18 to 25.4) ng/mL, respectively. The IgM titers within 3 to 7 days and 7 to 14 days increased rapidly to 1.8‐fold (P < 0.001) and 3.6‐fold (P < 0.001) those within the first day; the IgG titers increased to 5.8‐fold (P < 0.001) and 10.9‐fold (P < 0.001).
Booster vaccinated controls had higher first IgG titers compared with unvaccinated controls (3.1‐fold; P = 0.001) or booster vaccinated VDD cases (2.1‐fold; P = 0.02).
Conclusions
Booster vaccination and non‐VDD status may have an interactive boosting effect on IgG production of Omicron variant‐infected adults. Further randomized clinical trials may be needed to determine whether booster vaccination combined with VDD correction improves the humoral immunity to Omicron variants.
Publication and source details
Original title: Interactive effect of booster vaccination and vitamin D status on antibody production of Omicron variant‐infected adults: A real‐world cohort study
Denggao Peng; Yanzhang Gao; Zhichao Liu; Jiawei Zheng; Yingxia Liu
The Clinical Respiratory Journal · 2023
* CorrespondenceYingxia Liu, National Key Disciplines for Infectious Diseases, Graduate Collaborative Training Base of Shenzhen Third People's Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Email: yingxialiu@hotmail.com
© 2023 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Institutional Clinical Project of Shenzhen Third People's Hospital2022100
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T06:04:19.479857+00:00
DOI: 10.1111/crj.13694 · PMC10542990